How is your business helping to solve the health, social, or economic challenges created by COVID19?
The University of Tennessee, Department of Emergency Medicine conducted a 47 provider investigator-initiated crossover study on SafeBVM's device. The aim was to evaluate the efficacy of prolonged manual ventilation w/without the Bag Valve Mask (BVM) in case there is an increased demand and shortage of ventilators. The results showed that SafeBVM's device brought the performance with BVM closer to ventilators' performance in comparison with the BVM alone, making manual ventilation much safer. The device showed efficacy and safety in controlling pressure and tidal volume being delivered to the patient.
Does your business contribute most to recovery, response, or resilience?
Recovery - we're positioned to support in the recovery of those directly affected.,Response - we're responding directly to issues caused or exacerbated by the COVID-19 outbreak.
What is the stage of your product development?
I have a market-ready product/service. I could sell it to customers
What strengths does your team bring? Include skills and personal experience with the problem.
Haris Shekhani has extensive clinical research and sales background with 40+ publications. Prathamesh Prabhudesai has medical device operations and strategy experience and has worked with healthcare-focused VC firms. Both founders graduated from Georgia Tech's Biodesign program and have hands-on experience in new product development and commercialization. SafeBVM's advisors are Dr. Holley, EMS Director of Tennessee, Bill Midgett, ex-President CR Bard, Casey McGlynn, Corporate Attorney at WSGR, and Prof. Deshpande, a luminary in respiratory therapy.
What countries do you operate in?
USA
Is your company headquartered in a US "Opportunity Zone"?
Yes
